U.S. stocks closed down on Friday, with the chip sector selloff extending to a wider risk-off move. The S&P 500 dropped 0.9% and the Nasdaq declined 1.3%.
Intuitive Surgical was poised to lose roughly $16.3 billion in market capitalization, based on its premarket price of $357. The Nasdaq cash market had not yet opened.
Shares of Intuitive Surgical dropped over 10% in after-hours trading on Thursday. The surgical-robot manufacturer surpassed expectations but maintained its 2026 procedure guidance.
Intuitive Surgical, Inc. sank 6.2% on Tuesday, on the same day HCA Healthcare, Inc. disclosed falling surgical volumes, creating an unusually timely demand test before the robotic-surgery maker’s second-quarter report. The stock’s valuation of 46.4 times trailing earnings leaves little room for a soft utilization number.
Intuitive Surgical, Inc. shares rose Thursday, but the bounce did little to mend losses racked up from January through July. The robotic-surgery name was up 4.7% at $421.42 as of 1:46 p.m. EDT, after opening at $409.81 and hitting $423.30 at the high.
Intuitive Surgical Inc. closed out the week higher, but Friday’s close flattered the five-day move. Shares ended Friday up 1.25% at $404.70 on June 26. The weekly advance came in at just 0.43%, according to the company’s LSEG-powered price tool. The stock traded between a low of $398.89 and a high of $412.54 during the week. The range was tight for ISRG, which is still off sharply in 2026.
Intuitive Surgical shares slipped over a choppy, holiday-shortened week, while the major indexes kept rising to new records. That has put another spotlight on the robotic-surgery maker’s ability to convert a run of solid procedure growth into share gains.
Intuitive Surgical slid over 4% Wednesday afternoon, trading close to session lows. Shares were last seen at $416.43, off $20.21, after dipping to $415.00. The move put the surgical-robotics stock in line with a broader slump in medical-device names.
Shares of Intuitive Surgical dropped to a new 52-week low on Monday, deepening this year’s steep 2026 selloff. Demand for its da Vinci surgical robots has remained strong, but that hasn't stopped the slide.
Shares of Intuitive Surgical Inc. slid 6.6% on Monday, dropping as low as $417.80 and pushing the robotic surgery heavyweight to levels not seen in a year or more. By the end of the U.S. regular session, the stock managed to claw back to $420.22. The iShares U.S. Medical Devices ETF also lost ground, down roughly 3%.
Shares of Intuitive Surgical finished Friday in positive territory, pushing their rebound further after the company raised its 2026 growth forecast and flagged increased demand for its da Vinci surgical systems. According to LSEG data, the stock wrapped up April 24 at $482.22, climbing from $451.29 on April 21.
Intuitive Surgical shares ticked up on Wednesday, staying close to $480 in afternoon trading following a steep two-day drop. By 2:47 p.m. ET, the surgical-robotics company’s stock had climbed roughly 0.2% to $480.02, fluctuating between $465.81 and $482.18 earlier in the session.
Intuitive Surgical shares edged down 0.7% on Friday, closing at $504.22 on the Nasdaq. Investors are cautious heading into Monday following a filing that revealed the company’s chief medical officer offloaded stock. The price fluctuated between $501.44 and $510.75, with roughly 1.7 million shares traded.
Intuitive Surgical shares dipped 0.66% on Friday, settling at $504.22 and stretching their decline to two days after a 2.78% fall on Thursday. The stock fluctuated between $501.39 and $511.03, with roughly 1.7 million shares traded, while the S&P 500 slipped 0.43%.
Shares of Intuitive Surgical, Inc. slipped 0.7% to $525.09 Tuesday, despite a fresh U.S. approval for its newest da Vinci 5 surgical robot. Meanwhile, the broader market moved higher, with the S&P 500 ETF gaining roughly 0.5% and the Nasdaq-focused QQQ rising about 0.9%.
Shares of Intuitive Surgical climbed to $528.81 on Nasdaq, marking roughly a 1% gain from the prior close. The uptick followed news that the U.S. Food and Drug Administration approved its da Vinci 5 surgical robot for select cardiac procedures.
Intuitive Surgical shares climbed roughly 1% Monday following U.S. regulatory clearance of its newest da Vinci 5 robot for select heart procedures, providing a new boost after the stock’s swings post-earnings last week.
Intuitive Surgical shares closed Friday at $523.99, slipping roughly 0.4% following the company’s cautious growth forecast for 2026. U.S. markets will resume trading on Monday.
Intuitive Surgical shares ended Friday 0.4% lower at $523.99, with investors digesting a quarterly beat offset by a weaker growth forecast and higher tariff expenses.
Intuitive Surgical shares dipped 0.35% to end Friday at $523.99, as investors digested the company’s 2026 forecast following its recent quarterly report.